Product/Composition:- | Interferon Alfa-2b |
---|---|
Strength:- | 3 million IU/vial, 5 million IU/vial, 10 million IU/vial |
Form:- | Lyophilized Powder for Injection |
Reference Brands:- | Intron A® (EU & US), Roferon-A®(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Interferon Alfa-2b Injection is used to treat chronic hepatitis B and C by boosting the immune response to fight viral infections. Available as lyophilized powder and pre-filled syringes (3–10 million IU), it’s made under EU-GMP and USFDA standards. Suitable for B2B supply and licensing, it includes full regulatory dossiers for easy registration in global markets.
Interferon Alfa-2b Injection is a recombinant cytokine used primarily in the treatment of chronic hepatitis B and C, certain cancers, and viral infections. It works by modulating the immune system to inhibit viral replication and enhance antiviral responses. Available as sterile lyophilized powder or ready-to-use injections, commonly in strengths of 3 million IU, 5 million IU, and 10 million IU per vial. Manufactured under EU-GMP and USFDA standards, it is ideal for B2B supply, hospital tenders, and licensing. Full regulatory dossiers and stability data support rapid registration across regulated markets.